Skip to search formSkip to main contentSkip to account menu

roxindole

Known as: roxindol 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

EMD 49980

Broader (2)

IndolesPyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Endocrine characterization of the new dopamine autoreceptor agonist roxindole.
Roxindole (5-Hydroxy-3-(4-phenyl-1,2,3,6-tetrahydropyridil-(1)-butyl)-indol) is a newly developed compound with a high dopamine… 
2005
2005
Roxindole, a dopamine autoreceptor agonist, in the treatment of major depression
Roxindole is a potent autoreceptor-“selective” dopamine agonist originally developed for the treatment of schizophrenic syndromes… 
2005
2005
Roxindole, a potential antidepressant I. Effect on the dopamine system
SummaryRoxindole (EMD 49980, 5-hydroxy-3-[4-(4-phenyl-1,2,3,6-tetrahydropyridyl(1))-butyl(1)]-indole mesylate), a selective… 
2004
2004
Opioid and monoamine systems mediate the discriminative stimulus of tramadol in rats.
1999
1999
Involvement of dopamine D2 and 5-HT1A receptors in roxindole-induced antinociception.
Roxindole, a DA D2 receptor agonist (2-16 mg/kg) produced dose-dependent increase in percentage antinociception. The effect which… 
1995
1995
Binding properties of the naturally occurring human 5-HT1A receptor variant with the Ile28Val substitution in the extracellular domain
The cDNA from a schizophrenic patient heterozygous for a mutation of the 5-HT1A receptor gene was used to clone the variant and… 
1994
1994
Roxindole, a dopamine autoreceptor agonist, in the treatment of positive and negative schizophrenic symptoms.
Twenty schizophrenic inpatients with either predominantly positive or predominantly negative symptoms were treated with the… 
1994
1994
Treatment of prolactinoma patients with the new non-ergot dopamine agonist roxindol: first results
We studied the effects of the new non-ergot D2-dopamine agonist roxindol for the treatment of human prolactinomas. Roxindol is a… 
Review
1993
Review
1993
Dopamine autoreceptor agonists in the treatment of schizophrenic disorders
1991
1991
Antipsychotic Efficacy of the Dopaminergic Autoreceptor Agonist EMD 49980 (Roxindol)
EMD 49980 is a dopamine agonist with selective affinity to dopamine autoreceptors. Following pharmacological findings in animal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)